Leap Therapeutics Inc
LPTX - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$135.65M
Close$
$0.20
74.3% downside
Current Fair Value
74.3% downsideOvervalued by 74.3% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $135.65 Million |
|---|---|
| Enterprise Value | $128.16 Million |
| Earnings per Share | $0.07 |
| Beta | 0.09 |
| Outstanding Shares | 176,260,808 |
Return
| Return on Equity | 26.49% |
|---|---|
| Return on Assets | 25.81% |
| Return on Invested Capital | -28.72% |
Valuation & Multiples
| P/E Ratio | 5.05 |
|---|---|
| PEG | -0.9 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 613.21 |
| Enterprise Value to EBIT | -3.16 |
| Enterprise Value to Net Income | 3 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Last Earnings Call
Report Date
May 18, 2026
EPS Estimate
$-0.04
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.53, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.5326▼ 143.53% |
|---|---|
| Total Calls | 871,500▲ 207.30% |
| Total Puts | 464,200▼ 16.82% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 4.36%▼ 8.68% |
|---|---|
| Total Invested | $6.24M▼ 37.66% |
| Investors Holding | 47▲ 4.00% |
About Leap Therapeutics Inc
6 employees
CEO: Douglas E. Onsi
Cypherpunk Technologies Inc. is a privacy-focused technology company that combines a digital asset treasury strategy centered on Zcash (ZEC) with the development of novel cancer therapies through its subsidiary. The company's mission is ...